Anderson Woodrow D
Chief Accounting Officer
Anderson Woodrow D has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, Anderson Woodrow D is listed as Chief Accounting Officer at Indivior Pharmaceuticals, Inc. Inside the rolling window, Anderson Woodrow D reported 2 open-market purchases totaling $108K in INDV and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,500 INDV shares on Aug 5, 2026, worth $54K.
Companies traded
Other insiders at INDV
Insider Buying
$108K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Anderson Woodrow D made?
Anderson Woodrow D has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Anderson Woodrow D trade?
Anderson Woodrow D has filed SEC Form 4 disclosures for 1 company, including INDV.
When was Anderson Woodrow D's most recent SEC Form 4 filing?
Anderson Woodrow D's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is Anderson Woodrow D's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Anderson Woodrow D is listed as Chief Accounting Officer.
What is Anderson Woodrow D's total buy and sell value in the current window?
Inside the rolling retention window, Anderson Woodrow D bought $108K and sold $0 based on SEC Form 4 filings.
What was Anderson Woodrow D's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,500 INDV shares on 2026-08-05, worth $54K, per SEC Form 4 filings.